Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
A Phase 2 Multicenter, Randomized, Placebo Controlled Study to Assess the Safety and Efficacy of CC-486 (Oral Azacitidine) in Combination With MK-3475 Versus MK-3475 Alone in Subjects With Previously Treated Locally Advanced and/or Metastatic Non-small Cell Lung Cancer.
For more information, please visit ClinicalTrials.gov
|Patient Population||Investigational Product(s)||Phase||Status|
|NSCLC||CC-486 and Pembrolizumab||II||Open and Accruing|